• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. G2 FILTER SYSTEM - FEMORAL; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. G2 FILTER SYSTEM - FEMORAL; VENA CAVA FILTER Back to Search Results
Catalog Number RF310F
Device Problems Difficult to Remove (1528); Malposition of Device (2616); Patient Device Interaction Problem (4001)
Patient Problem Abdominal Pain (1685)
Event Date 05/17/2012
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: the device history records have been reviewed with special attention to the raw materials, subassemblies, manufacturing process, and quality control testing.This lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately five months of post deployment, filter retrieval attempt was performed.Ultrasound guidance was utilized, and the right jugular vein was cannulated.A 5- french sheath was used following micro catheter puncture.Two separate guide wires used with placement of a diagnostic catheter to the level of the proximal right common iliac vein.Two separate views were performed that include an anteroposterior and oblique view of the cava.Note was made of an approximate 70% angulation of the caval filter within the cava.The filter limbs were away from any renal venous inflow.Several views suggested the legs extended outside the caval wall.Due to the position of the filter, attempt for its removal was not made percutaneously.The cava was patent otherwise.Filter retrieval could not be performed.Around six years and nine months later, computed tomography of abdomen without contrast was performed, and result showed that there was an inferior vena cava filter located about 2.5 cm proximal to the left renal vein.The filter showed abnormal horizontal orientation.The hub of the filter was seen abutted the rightward aspect of the inferior vena cava.The struts were seen penetrated the wall of the inferior vena cava.Four struts were seen extended to the level of the aorta.2 were seen along the anterior aspect and other 2 were seen along the dorsal aspect with no evidence of perforation.One strut was seen abutted the dorsal aspect of the duodenal sweep with no discrete perforation.The other struts were seen in the retroperitoneal space.Therefore, the investigation is confirmed for perforation of inferior vena cava (ivc), filter tilt and retrieval difficulties.Per medical records, an attempt was made to engage the apex of the filter but was unsuccessful due to filter tilt and perforation of inferior vena cava (ivc).This could have contributed to the retrieval difficulties.However, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.(expiry date: 04/2014).
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient in conjunction with or before bariatric procedure.At some time post filter deployment, it was alleged that the filter tilted and struts perforated.The device has not been removed after an attempted but unsuccessful percutaneous removal procedure.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G2 FILTER SYSTEM - FEMORAL
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key12105782
MDR Text Key259588819
Report Number2020394-2021-80533
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062887
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 07/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberRF310F
Device Lot NumberGFVD1894
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/08/2021
Initial Date FDA Received07/02/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/20/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
COUMADIN, PERCOCET, METFORMIN; FLINTSTONE, CALCIUM, AND ALBUTEROL; LISINOPRIL, VENTOLIN INHALER, PEPCID
Patient Outcome(s) Other;
Patient Age29 YR
Patient Weight204
-
-